{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-24-000006","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2024-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.322015+00:00","generated_at":"2026-06-04T11:11:01.336989+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aspira Women's Health appoints Sandra Milligan as President effective April 1, 2024","bullets":["Dr. Sandra Milligan appointed President, reporting to CEO Nicole Sandford, effective April 1, 2024.","Base salary of $400,000; eligible for bonus up to 50% of base salary based on corporate goals.","Granted stock option for 30,000 shares, vesting 25% per year over four years.","Severance: 6 months salary and COBRA if terminated without cause after 12 months of employment.","Over 25 years healthcare experience; previously EVP R&D at Organon, roles at Amgen, Genentech, Merck."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-24-000006","json":"https://secwatch.observer/filing/0000926617-24-000006.json","markdown":"https://secwatch.observer/filing/0000926617-24-000006.md","text":"https://secwatch.observer/filing/0000926617-24-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661724000006/0000926617-24-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661724000006/awh-20240316x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:11:01.336989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e90c44d43e","claim":"Sandra Milligan was appointed as President at Aspira Women's Health Inc..","evidence_excerpt":"On March 16, 2024, Aspira Women’s Health Inc. (the “Company”) expanded its senior management team with the addition of Sandra Milligan, M.D., J.D. as President, effective as of April 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661724000006/0000926617-24-000006-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}